Quantum 9 To Provide Consulting, Technology and Implementation to Canada-Based Vida Cannabis Corp.

In a move to expand its service base across North America, Quantum 9 signed on to provide consulting, technology and implementation services for Canada-based Vida Cannabis Corp. (Vida Cannabis) in April.

As the pre-eminent authority on cannabis cultivation and technology in North America, Quantum 9 will assist in finalizing Vida Cannabis’s MMPR application. Quantum 9’s extensive experience working with Health Canada has provide the framework for assisting in the administrative process of licensure applications. With the help of Quantum 9 Vida Cannabis has completed the initial submission to Health Canada. 

In addition, Quantum 9 will help design a state-of-the-art production facility that will be nearly twice the size of any currently licensed producer in Canada. Quantum 9 has been on location in Stellarton, Nova Scotia where Vida Cannabis has secured a 50-year irrevocable approval unanimously from the local municipality to operate a medical marijuana production plant. Personnel are in the process of finalizing the security and facility design to optimize the build-out of Vida's 315,000-square-foot facility, including an initial production area of approximately 30,000 square feet, with a roadmap for expansion driven by market demand.

Quantum 9’s Derek Ogden is helping to finalize and implement the minimum level-9 security plan, with some areas of the facility utilizing level 10 and 11 measures. The highly secure facility includes a fully engineered concrete floor, 18-foot-high concrete walls and a steel roof.

Quantum 9 CEO Michael Mayes stated: "We are very excited about our partnership with Vida Cannabis. Their executive staff rivals that of the best we have seen in the industry and we are excited to bring our expert experience to ensure a best-in-class operation."

Vida Cannabis is focused on developing its production footprint in the quickly growing global marketplace for legal medicinal and recreational marijuana. Initial operations will be focused on the Canadian market and will be looking to acquire commercial production licenses under Health Canada’s Marihuana for Medical Purposes Regulations – a distinction for best-in-class producers.

Vida Cannabis will continue to evaluate potential markets as regulatory bodies around the world pass legislation enabling the production and distribution of medicinal or recreational marijuana.

Canada opened its medical marijuana free market in October 2013, phasing out small operations for large-scale, standardized and certified operations. Health Canada has placed no limits on the number of facilities, but patients can only purchase from a single producer. Federal projections for the industry are around $1.3 billion by 2024.




There are no comments

Add yours